PAVmed Inc. Costs and Expenses
PAVmed Inc. (PAVM) reported Costs and Expenses of $7.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-08-13
- PAVmed Inc. costs and expenses for the quarter ending 2026-06-30 was $7.05M, a 49.44% increase year-over-year.
- PAVmed Inc. costs and expenses for the quarter ending 2026-03-31 was $8.06M, a 47.73% increase year-over-year.
- PAVmed Inc. costs and expenses for the quarter ending 2025-12-31 was $6.86M, a 31.90% increase year-over-year.
- PAVmed Inc. costs and expenses for the quarter ending 2025-09-30 was $4.85M, a 61.44% decline year-over-year.
- PAVmed Inc. costs and expenses for fiscal 2025 was $21.88M, a 53.93% decline from fiscal 2024.
- PAVmed Inc. costs and expenses for fiscal 2024 was $47.48M, a 33.36% decline from fiscal 2023.
- PAVmed Inc. costs and expenses for fiscal 2023 was $71.25M, a 22.10% decline from fiscal 2022.
- PAVmed Inc. costs and expenses for fiscal 2022 was $91.46M, a 66.62% increase from fiscal 2021.
| Period end | Costs and Expenses 3 month | Costs and Expenses 3 month as first filed | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 9 month as first filed | Costs and Expenses 12 month | Costs and Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.05M 10-Q · filed 2026-08-13 | $15.11M 10-Q · filed 2026-08-13 | $21.97M derived: sum of 3 quarters · filed 2026-08-13 | $26.82M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $8.06M 10-Q · filed 2026-05-14 | $14.91M derived: sum of 2 quarters · filed 2026-05-14 | $19.76M derived: sum of 3 quarters · filed 2026-05-14 | $24.48M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | $6.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $11.70M derived: sum of 2 quarters · filed 2026-03-27 | $16.43M derived: sum of 3 quarters · filed 2026-08-13 | $21.88M 10-K · filed 2026-03-27 | |||
| 2025-09-30 | $4.85M 10-Q · filed 2025-11-12 | $9.57M derived: sum of 2 quarters · filed 2026-08-13 | $15.02M 10-Q · filed 2025-11-12 | $20.22M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $4.72M 10-Q · filed 2026-08-13 | $10.17M 10-Q · filed 2026-08-13 | $15.37M derived: sum of 3 quarters · filed 2026-08-13 | $27.95M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $5.45M 10-Q · filed 2026-05-14 | $10.65M derived: sum of 2 quarters · filed 2026-05-14 | $23.23M derived: sum of 3 quarters · filed 2026-05-14 | $37.89M derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $17.77M derived: sum of 2 quarters · filed 2026-03-27 | $32.43M derived: sum of 3 quarters · filed 2026-03-27 | $47.48M 10-K · filed 2026-03-27 | |||
| 2024-09-30 | $12.57M 10-Q · filed 2025-11-12 | $27.24M derived: sum of 2 quarters · filed 2025-11-12 | $42.28M 10-Q · filed 2025-11-12 | $59.72M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $14.66M 10-Q · filed 2025-08-14 | $29.71M 10-Q · filed 2025-08-14 | $47.14M derived: sum of 3 quarters · filed 2025-08-14 | $63.46M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $15.05M 10-Q · filed 2025-05-15 | $32.48M derived: sum of 2 quarters · filed 2025-05-15 | $48.80M derived: sum of 3 quarters · filed 2025-05-15 | $65.45M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $17.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $33.75M derived: sum of 2 quarters · filed 2025-03-24 | $50.40M derived: sum of 3 quarters · filed 2025-03-24 | $71.25M 10-K · filed 2025-03-24 | |||
| 2023-09-30 | $16.32M 10-Q · filed 2024-11-14 | $32.97M derived: sum of 2 quarters · filed 2024-11-14 | $53.81M 10-Q · filed 2024-11-14 | $78.53M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | $16.65M 10-Q · filed 2024-08-12 | $37.50M 10-Q · filed 2024-08-12 | $62.21M derived: sum of 3 quarters · filed 2024-08-12 | $85.65M derived: sum of 4 quarters · filed 2024-08-12 | |||
| 2023-03-31 | $20.85M 10-Q · filed 2024-05-13 | $45.56M derived: sum of 2 quarters · filed 2024-05-13 | $69.00M derived: sum of 3 quarters · filed 2024-05-13 | $92.49M derived: sum of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | $24.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $48.16M derived: sum of 2 quarters · filed 2024-03-25 | $71.64M derived: sum of 3 quarters · filed 2024-03-25 | $91.46M 10-K · filed 2024-03-25 | $91.30M 10-K · filed 2023-03-14 | ||
| 2022-09-30 | $23.44M 10-Q · filed 2023-11-13 | $23.39M 10-Q · filed 2022-11-14 | $46.93M derived: sum of 2 quarters · filed 2023-11-13 | $66.75M 10-Q · filed 2023-11-13 | $66.69M 10-Q · filed 2022-11-14 | $86.73M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $23.48M 10-Q · filed 2023-08-14 | $43.31M 10-Q · filed 2023-08-14 | $63.29M derived: sum of 3 quarters · filed 2023-08-14 | $77.16M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $19.82M 10-Q · filed 2023-05-15 | $39.80M derived: sum of 2 quarters · filed 2023-05-15 | $53.67M derived: sum of 3 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $19.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $33.85M derived: sum of 2 quarters · filed 2023-03-14 | $54.89M 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | $13.87M 10-Q · filed 2022-11-14 | $34.91M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InspireMD, Inc. (NSPR) | $0.033B | ||
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |